cov pid 1 [ . . . . : . . . 80 1 CAA18093/1-173 100.0% 100.0% QAASPRWEPQIAVLCEAGQIYQPQYLSEEGRWVTDLSKKTTGPTCLRDKMDLLDYCKKAYPNRDITNIVESSHYQKIGGW 2 1293850/1-169 93.6% 36.1% SKRHEKFIPMVAFSCGYRNQYMTEE----GSWKTDDERYAT---CFSGKLDILKYCRKAYPSMNITNIVEYSHEVSISDW 3 E251261/1-165 94.8% 37.9% GNAGLLAEPQIAMFCGRLNMHMNVQN---GKWDSDPSGTKT---CIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNW 4 APP1_HUMAN/1-16 95.4% 35.1% GAPEAPGSAQVAGLCGRLTLHRDLRT---GRWEPDPQRSRR---CLRDPQRVLEYCRQMYPELQIARVEQATQAIPMERW 5 APP2_RAT/1-163 93.6% 36.2% GTGFAVAEPQIAMFCGKLNMHVNIQT---GKWEPDPTGTKS---CLGTKEEVLQYCQEIYPELQITNVMEANQPVNIDSW consensus/100% tt....h.s.lAh.Cthhp.a.s......GpW.sD.pt.tp...Chts..tlLpYCpphYPphpIspl.p.sp...httW consensus/90% tt....h.s.lAh.Cthhp.a.s......GpW.sD.pt.tp...Chts..tlLpYCpphYPphpIspl.p.sp...httW consensus/80% usst.hhpPQlAhhCGthshahs.p....G+WcsDsptppo...ClpsK.clLpYCpchYPphpITNlhEusp.lsIpsW consensus/70% usst.hhpPQlAhhCGthshahs.p....G+WcsDsptppo...ClpsK.clLpYCpchYPphpITNlhEusp.lsIpsW cov pid 81 . 1 . . . . : . 160 1 CAA18093/1-173 100.0% 100.0% CRQGALNAAKCKGSHRWIKPFRCL-GPFQSDALLVPEGCLFDHIHNASRCWPFVRWNQTGAAACQER------GMQMRSF 2 1293850/1-169 93.6% 36.1% CREEGS---PCKWT-HSVRPYHCIDGEFHSEALQVPHDCQFSHVNSRDQCNDYQHWKDEAGKQCKTKKSKGNKDMIVRSF 3 E251261/1-165 94.8% 37.9% CKRGRK---QCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEK------STNLHDY 4 APP1_HUMAN/1-16 95.4% 35.1% CGGSRSG--SCAHPHHQVVPFRCLPGEFVSEALLVPEGCRFLHQERMDQCESSTRRHQEAQEACSSQ------GLILHGS 5 APP2_RAT/1-163 93.6% 36.2% CRRDKK---QCRSH--IVIPFKCLVGEFVSDVLLVPENCQFFHQERMEVCEKHQRWHTVVKEACLTE------GMTLYSY consensus/100% Ctttt.....Ct.....lhPa+Cl.G.F.S-sL.VPctC.F.H.pphp.C....+hpp.stttC.pp......sh.hhs. consensus/90% Ctttt.....Ct.....lhPa+Cl.G.F.S-sL.VPctC.F.H.pphp.C....+hpp.stttC.pp......sh.hhs. consensus/80% C+pstp...pC+tp.+.VhPa+CLsGEFhS-ALLVP-sCpF.H.cph-.Cpsa.+W+p.utcsCppc......uh.l+ua consensus/70% C+pstp...pC+tp.+.VhPa+CLsGEFhS-ALLVP-sCpF.H.cph-.Cpsa.+W+p.utcsCppc......uh.l+ua cov pid 161 . ] 180 1 CAA18093/1-173 100.0% 100.0% AMLLPCGISVFSGVEFVCCP 2 1293850/1-169 93.6% 36.1% AVLEPCALDMFTGVEFVCCP 3 E251261/1-165 94.8% 37.9% GMLLPCGIDKFRGVEFVCCP 4 APP1_HUMAN/1-16 95.4% 35.1% GMLLPCGSDRFRGVEYVCCP 5 APP2_RAT/1-163 93.6% 36.2% GMLLPCGVDQFHGTEYVCCP consensus/100% uhL.PCu.s.FpGsEaVCCP consensus/90% uhL.PCu.s.FpGsEaVCCP consensus/80% uMLLPCGlDhFpGVEaVCCP consensus/70% uMLLPCGlDhFpGVEaVCCP